Get started
Author

Nicola Reggidori

Observed names: N. Reggidori, Nicola ReggidorI
ORCID: 0000-0001-7513-8846
Observed ORCID: 0000-0001-7513-8846
OpenAlex ID: A5087801156
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs
2023 · Nicola Reggidori, Laura Bucci, et al. · JHEP Reports · 20
PDF
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
2022 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 17
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care
2024 · Benedetta Stefanini, Laura Bucci, et al. · Digestive and Liver Disease · 9
PDF
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison
2025 · Felice Giuliante, Simone Famularo, et al. · JHEP Reports · 6
Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications
2024 · Luca Ielasi, Enrico Fulco, et al. · Gastroenterology Insights · 6
Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study
2022 · Francesco Palmese, Maria Elena Bonavita, et al. · Internal and Emergency Medicine · 5
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
2024 · Maurizio Biselli, Nicola Reggidori, et al. · Cancers · 4
PDF
Development and internal validation of a multivariable model for the prediction of the probability of 1-year readmission to the emergency department for acute alcohol intoxication
2023 · Francesco Palmese, Maria Elena Bonavita, et al. · Internal and Emergency Medicine · 4
Lack of substantial improvements in the landscape of alcohol-related hepatocellular carcinoma in the last 15 years: The need to improve cancer prevention and surveillance
2023 · N. Reggidori, L. Bucci, et al. · Digestive and Liver Disease · 3
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosin-kinase inhibitors: a real-world analysis
2022 · B. Stefanini, L. Bucci, et al. · Digestive and Liver Disease · 2
Clinical Presentation and Therapeutic Approach of Hepatic Sarcoidosis
2026 · Vittoria Benintende, Luca Bettazzoni, et al. · Livers · 1
Comparing ECOG-PS and Charlson Comorbidity Index for stratification of hepatocellular carcinoma prognosis across treatments
2026 · Simone Famularo, Flavio Milana, et al. · European Journal of Surgical Oncology
PDF
FRI-117 Impact of sarcopenia on medium-long-term survival of patients with hepatocellular carcinoma treated with lenvatinib
2025 · Lorenzo Lani, Nicola ReggidorI, et al. · Journal of Hepatology
Role of P-shear wave hepatic elastography in prediction of high-risk varices in patients affected by compensated advanced chronic liver disease
2024 · N. Reggidori, M.L. Lazzari, et al. · Digestive and Liver Disease
Outcomes of Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced hepatocellular carcinoma in the era of immunotherapy: A real-life comparison with best supportive care
2023 · B. Stefanini, L. Bucci, et al. · Digestive and Liver Disease
Potential faesability of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma: a real-world analysis
2022 · Benedetta Stefanini, Laura Bucci, et al. · Journal of Hepatology
T.08.10 Impact of Sarcopenia on Survival of Patients Affected by Advanced Hepatocellular Carcinoma Treated With Sorafenib
2022 · N. Reggidori, L. Lani, et al. · Digestive and Liver Disease
Prognostic impact of sarcopenia on patients with advanced hepatocellular carcinoma treated with sorafenib
2022 · L. Lani, N. Reggidori, et al. · Digestive and Liver Disease
More than a “monstrous obesity”! Time to overcome the “anti‐fat” bias
2020 · Francesco Palmese, Nicola Reggidori, et al. · Clinical Obesity
Works count: 19
Citation count: 77
H-index: 5
I10-index: 2
Year
Topic
Type